Key result
Obstructive sleep apnea was diagnosed in 64% of IHD patients, accounting for 72% of nocturnal arrhythmias and 92% of cardiac pauses, while worsening quality of life in heart failure.
Why the study?
The contribution of obstructive sleep apnea syndrome to nocturnal arrhythmias and quality of life in patients with ischemic heart disease is not well defined, and the scarcity of sleep laboratories in Uzbekistan creates a need for simpler screening methods.
Does obstructive sleep apnea syndrome contribute to nocturnal cardiac rhythm and conduction disturbances and reduce quality of life in hospitalized patients with ischemic heart disease, and can rheopneumography and pulse oximetry serve as effective screening tools?
Cross-Sectional (n=81)
Does obstructive sleep apnea syndrome contribute to nocturnal cardiac rhythm and conduction disturbances and reduce quality of life in hospitalized patients with ischemic heart disease, and can rheopneumography and pulse oximetry serve as effective screening tools?
Answers are grounded in this paper and cite their sources.
In patients with ischemic heart disease, obstructive sleep apnea is closely linked to the vast majority of nocturnal conduction pauses regardless of apnea severity, impairs quality of life in those with heart failure, and can be screened with reasonable sensitivity using rheopneumography.
Background. Obstructive sleep apnea syndrome (OSAS) frequently coexists with ischemic heart disease (IHD), but its contribution to nocturnal arrhythmias and to the quality of life of these patients is not well defined. Sleep laboratories are scarce in Uzbekistan, so simpler screening methods are needed. Aim. To determine the association between OSAS and cardiac rhythm and conduction disturbances, to assess its effect on the clinical course and quality of life of patients with IHD, and to evaluate RR-interval dynamics, rheopneumography (RPG) and pulse oximetry as screening tools for apnea. Methods. Eighty-one hospitalized patients (63 men and 18 women aged 37–80 years, mean age 57.1 ± 2.3 years) with clinical features suggestive of sleep apnea underwent 24-hour cardiorespiratory monitoring that combined 12-lead electrocardiography, single-channel RPG, pulse oximetry, nasal airflow and snoring recording. Quality of life was assessed with the WHOQOL-BREF and a sleep apnea–specific questionnaire based on the Calgary Sleep Apnea Quality of Life Index (SAQLI). Results. OSAS was diagnosed in 52 patients (64%): mild in 21, moderate in 11 and severe in 20. Of 25 patients with nocturnal rhythm or conduction disturbances, 18 (72%) had arrhythmias linked to apnea episodes, most often pauses caused by sinoatrial (7 patients) or atrioventricular (5 patients) block; 92% of all recorded pauses occurred during apnea. The longest asystole (7.9 s) was recorded in a patient with mild OSAS. Nine patients (11%) had asystole-related arrhythmias that required consideration of pacemaker implantation. Pulse oximetry had a sensitivity of 0.56 and a specificity of 0.96 for apnea episodes; RPG detected 79% of episodes with a specificity of 0.85. In patients with chronic heart failure, the mean SAQLI score was 3.1 ± 1.2 with a high apnea–hypopnea index (AHI) and 4.7 ± 0.3 with a low AHI (p < 0.01). Conclusions. Most nocturnal rhythm and conduction disturbances in patients with IHD are associated with apnea, and severe pauses can occur regardless of OSAS severity. Patients with nocturnal pauses should be evaluated for sleep-disordered breathing. RPG is the most sensitive of the screening methods studied, and OSAS has the strongest negative effect on quality of life in patients with heart failure.
No takes yet. Share an insight, caveat, or question.
Shoalimova et al. (2026) conducted a cross-sectional in Ischemic heart disease with clinical features suggestive of sleep apnea (n=81). Obstructive sleep apnea syndrome (OSAS) and 24-hour cardiorespiratory monitoring (rheopneumography, pulse oximetry, ECG) vs. Patients without OSAS or low apnea-hypopnea index (AHI) was evaluated on Association of nocturnal cardiac rhythm and conduction disturbances with apnea episodes, and quality of life (SAQLI score) (p=<0.01). Obstructive sleep apnea was diagnosed in 64% of IHD patients, accounting for 72% of nocturnal arrhythmias and 92% of cardiac pauses, while worsening quality of life in heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: